Nasri Hamid, Baradaran Azar
Hemodialysis Section, Hajar Medical, Educational and Therapeutic Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Saudi J Kidney Dis Transpl. 2007 Jun;18(2):215-9.
This study was designed to determine whether the serum levels of 25-OH vitamin D influence the occurrence of infection with Helicobacter Pylori (H.Pylori) in patients on maintenance hemodialysis (HD). The study subjects were patients with end-stage renal disease who were undergoing maintenance dialysis at the hemodialysis section, Hajar Medical, Educational and Therapeutic Center, Shahrekord, Iran. The serum 25-OH vitamin D level and serum H. Pylori specific IgG antibody titers were measured using an enzyme-linked immunosorbent assay (ELISA) method. A total of 36 patients were studied including 21 males and 15 females. The mean age of the study group was 47 (+/- 17) years. The mean level of serum 25-OH vitamin D was 0.5 +/- 18.7 nmol/L (median: 3.5) while the mean value of serum H.Pylori specific IgG antibody titer was 7.7 (+/-9.9) u/ml (median: 2 u/ml). Thus, a significant positive correlation was found between the levels of serum 25-OH vitamin D and serum H. Pylori specific IgG antibody titers (data adjusted for age, urea reduction rate, duration and dose of dialysis) (r=0.36, p=0.043). Our study suggests that vitamin D may positively affect the chronic inflammatory status of dialysis patients and may potentiate the immune response in such patients. Because of this immuno-modulatory effect, vitamin D analogs may offer new means to control the inflammatory status in patients on maintenance dialysis.
本研究旨在确定维持性血液透析(HD)患者血清25-羟基维生素D水平是否会影响幽门螺杆菌(H.Pylori)感染的发生。研究对象为在伊朗设拉子哈贾尔医学、教育和治疗中心血液透析科接受维持性透析的终末期肾病患者。采用酶联免疫吸附测定(ELISA)法测定血清25-羟基维生素D水平和血清幽门螺杆菌特异性IgG抗体滴度。共研究了36例患者,其中男性21例,女性15例。研究组的平均年龄为47(±17)岁。血清25-羟基维生素D的平均水平为0.5±18.7 nmol/L(中位数:3.5),而血清幽门螺杆菌特异性IgG抗体滴度的平均值为7.7(±9.9)u/ml(中位数:2 u/ml)。因此,在血清25-羟基维生素D水平和血清幽门螺杆菌特异性IgG抗体滴度之间发现了显著的正相关(数据经年龄、尿素清除率、透析时间和剂量校正)(r = 0.36,p = 0.043)。我们的研究表明,维生素D可能对透析患者的慢性炎症状态产生积极影响,并可能增强此类患者的免疫反应。由于这种免疫调节作用,维生素D类似物可能为控制维持性透析患者的炎症状态提供新的方法。